Early In-hospital Initiation of Pharmacotherapy for Smoking Cessation, Patients After ACS
Status:
Unknown status
Trial end date:
2018-12-01
Target enrollment:
Participant gender:
Summary
The hypothesis of this study is that combination of Varenicline treatment with nurse-led
hospital support during hospitalization and after discharge will result in clinically
significant higher long term abstinence rates in smokers with ACS, as compared with nurse led
support and placebo, without a significant increase in the risk of adverse events.
Phase:
N/A
Details
Lead Sponsor:
Sheba Medical Center
Collaborators:
Barzilai Medical Center Hadassah Medical Organization